Characterization of Vaginal, Urinary and Fecal Microbiomes in Women with Recurrent Urinary Tract Infections
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
AgeNot listed
SponsorHadassah Medical Organization
About this trial
The objectives are to evaluate whether variations in vaginal and/or urinary and/or fecal microbiome predispose postmenopausal women to recurrent cystitis. This will be explored using comparison of microbiome profiles between those with recurrent UTI compared to age-matched women without recurrent UTI.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Menopausal status
Two or more documented, culture-positive infections in the last six months or ≥3 infections in the last year Patients'
Disqualifiers
Neurogenic bladder condition
Known immunodeficiencies
Usage of antibiotics or probiotics within the previous month
Known renal calculi or anatomic malformations
Trial population
Menopausal women, with recurrent UTI and age-matched menopausal women without recurrent UTI.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
40 Participants
are grouped into 2 trial groupsGroup A: Recurrent Urinary tract infection
Group B: Healthy controls
Trial outcomes
Primary outcomes
1
Characterization of the microbiome using molecular methods.
Comparison of microbiome profiles between those with rUTI compared to healthy controls.
Time frame
1 yearSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov